Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The transfusion effect.

M Cecka, A Toyotome

    Clinical Transplants
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Pretransplant blood transfusions significantly improve kidney transplant graft survival, especially for certain racial groups and high-risk transplants. This benefit extends beyond the immediate post-transplant period, impacting long-term outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
    Same author

    Elderly transplant recipients may require less immunosuppression.

    Transplantation proceedings·2001
    Same author

    Report from the International Pancreas Transplant Registry--1998.

    Transplantation proceedings·1999
    Same author

    Clinical outcome of renal transplantation. Factors influencing patient and graft survival.

    The Surgical clinics of North America·1998
    Same author

    The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·1997
    Same author

    Allocation of cadaver kidneys.

    Lancet (London, England)·1996
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Transplantation Science

    Background:

    • Transplant centers are re-evaluating deliberate transfusion protocols due to perceived risks outweighing benefits.
    • Historically, pretransplant blood transfusions have demonstrated a positive impact on graft survival in kidney transplantation.
    • Recent trends suggest a potential decline in the long-term benefits of transfusions for non-transfused recipients.

    Purpose of the Study:

    • To analyze the impact of pretransplant blood transfusions on kidney graft survival.
    • To assess the effect of transfusion protocols on early rejection episodes and long-term graft outcomes.
    • To investigate the influence of transfusions on graft survival across different racial groups and specific transplant conditions.

    Main Methods:

    Related Experiment Videos

  • Retrospective analysis of kidney transplant recipient data.
  • Comparison of graft survival rates between transfused and non-transfused patients.
  • Evaluation of early rejection episodes and graft dysfunction in relation to transfusion status.

    • Main Results:

    • Pretransplant transfusions consistently improved 1-year graft survival, with notable benefits observed between 1982-1987 and a 3% improvement in 1988-1989.
    • While multiple transfusions were beneficial pre-cyclosporine, 2-3 transfusions appear optimal in recent transplants.
    • A concerning decrease in long-term survival for non-transfused recipients and those with 1-4 transfusions has been observed since 1985.
    • Transfusions reduced early rejection rates (26% vs. 42%) and improved graft survival (67% vs. 56%).
    • Transfusions enhanced 1-year graft survival across racial groups: Asians (7%), Blacks (6%), and Whites (4%).
    • Transfusions mitigated the negative impact of HLA-DR mismatching and young donor age (<16) on graft survival.

    Conclusions:

    • Pretransplant blood transfusions remain a significant factor in improving both short-term and potentially long-term kidney graft survival.
    • The optimal number of transfusions may have shifted from multiple to 2-3 in the modern era.
    • Transfusions offer crucial benefits for high-risk transplants, including those with HLA-DR mismatching and from young donors, and across diverse racial populations.